Proglucagon-derived peptides: Mechanisms of action and therapeutic potential
被引:72
作者:
Sinclair, EM
论文数: 0引用数: 0
h-index: 0
机构:
Toronto Gen Hosp, Dept Med, Banting & Best Diabet Ctr, Toronto, ON, CanadaToronto Gen Hosp, Dept Med, Banting & Best Diabet Ctr, Toronto, ON, Canada
Sinclair, EM
[1
]
Drucker, DJ
论文数: 0引用数: 0
h-index: 0
机构:Toronto Gen Hosp, Dept Med, Banting & Best Diabet Ctr, Toronto, ON, Canada
Drucker, DJ
机构:
[1] Toronto Gen Hosp, Dept Med, Banting & Best Diabet Ctr, Toronto, ON, Canada
Glucagon is used for the treatment of hypoglycemia, and glucagon receptor antagonists are under development for the treatment of type 2 diabetes. Moreover, glucagon-like peptide (GLP)-1 and GLP-2 receptor agonists appear to be promising therapies for the treatment of type 2 diabetes and intestinal disorders, respectively. This review discusses the physiological, pharmacological, and therapeutic actions of the proglucagon-derived peptides, with an emphasis on clinical relevance of the pepticles for the treatment of human disease.